KoreaMed Synapse

Go to TopGo to Top Go to BottomGo to Bottom


1	The first successful eculizumab rescue therapy of a kidney transplant recipient with atypical hemolytic uremic syndrome in South Korea: a case report Eun-Ki Min, Hyun Jeong Kim, Sinyoung Kim, Minsun Jung, Jin Seok Kim, Seung Hyeok Han, Kyu Ha Huh Korean J Transplant.2023;37(1):57-62. Published online 2023 January 20 DOI: http://dx.doi.org/10.4285/kjt.22.0050

2	Eculizumab as rescue therapy in a kidney transplant recipient with atypical hemolytic uremic syndrome: a case report Young Ju Oh, Joohyun Lee, Yeonmi Kim, Heungman Jun, Jongmin Sim, Myung-Gyu Kim, Cheol Woong Jung Korean J Transplant.2022;36(4):283-288. Published online 2022 November 11 DOI: http://dx.doi.org/10.4285/kjt.22.0027

3	Recurrent hemolytic uremic syndrome caused by DGKE gene mutation: a case report Baek Sup Shin, Yo Han Ahn, Hee Gyung Kang Child Kidney Dis.2022;26(1):58-62. Published online 2022 June 16 DOI: http://dx.doi.org/10.3339/ckd.22.024

4	Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort Chul Won Choi, Jun Ho Jang, Jin Seok Kim, Deog-Yeon Jo, Je-Hwan Lee, Sung-Hyun Kim, Yeo-Kyeoung Kim, Jong-Ho Won, Joo Seop Chung, Hawk Kim, Jae Hoon Lee, Min Kyoung Kim, Hyeon-Seok Eom, Shin Young Hyun, Jeong-A Kim, Jong Wook Lee Blood Res.2017;52(3):207-211. Published online 2017 September 25 DOI: http://dx.doi.org/10.5045/br.2017.52.3.207

5	The use of the complement inhibitor eculizumab (Soliris®) for treating Korean patients with paroxysmal nocturnal hemoglobinuria Jin Seok Kim, Jong Wook Lee, Byoung Kook Kim, Je-Hwan Lee, Jooseop Chung Korean J Hematol.2010;45(4):269-274. Published online 2010 December 31 DOI: http://dx.doi.org/10.5045/kjh.2010.45.4.269